OpenAI Pushes Into Clinical Data Amid Medical Malpractice Lawsuit
AI-generated image · US National Wire
The company is integrating Apple Health and medical records into ChatGPT just as a Florida man alleges the bot's dangerous medical advice nearly killed him.
OpenAI is attempting to pivot ChatGPT toward greater clinical utility, but the timing of its latest rollout suggests a disregard for the severe liability risks associated with AI-driven medical guidance.
On July 23, 2026, OpenAI launched "Health in ChatGPT," a feature allowing U.S. users aged 18 and older on Free, Go, Plus, and Pro plans to connect the chatbot to Apple Health and supported medical records. According to OpenAI, the integration allows the AI to access medications, lab results, sleep, activity, and recent visits to provide personalized responses and help users navigate their health history. The company noted that this shift follows testing of a dedicated health space that users frequently bypassed, with more than 70 percent of health-related queries occurring in general chats.
However, as reported by The Register, this launch occurred only one day after a Florida man filed a lawsuit in San Francisco Superior Court. The plaintiff alleges that ChatGPT provided "extremely dangerous medical recommendations" that discouraged him from seeking professional care while he suffered from a pulmonary embolism. The lawsuit claims the chatbot repeatedly assured the man his symptoms were not serious, leading to a hospitalization and years of required physical and psychological recovery.
OpenAI has attempted to distance itself from these clinical risks through various disclaimers. A company spokesperson told The New York Times and The Register that the chatbot is not intended for medical diagnosis or treatment and is not a substitute for professional medical care. OpenAI further claimed that its models—specifically GPT-5.5 Instant and GPT-5.6 Sol—have made "meaningful gains" in identifying when urgent care is necessary and explaining uncertainty.
Despite these claims, evidence of AI instability in healthcare remains a persistent concern. The Register highlighted several critical failures, including:
* A study finding LLMs failed at early differential diagnosis in over 80 percent of cases. * Findings from the Auditor General of Ontario showing AI note-taking systems used by doctors introduced medication errors and hallucinated information. * Research indicating AI chatbots are no more effective than standard search engines in helping users make health decisions.
OpenAI maintains that the new feature is built with privacy safeguards, stating that connected health data will not be used for advertising or to train foundation models. While the company asserts it worked with hundreds of physicians to test the tool, the juxtaposition of this rollout with active malpractice litigation underscores the tension between OpenAI's expansion goals and the potential for catastrophic medical errors.